ByViJay K. U. Nathan; B.Pharm, M.Tech (BioEngg), PhD
Patient-specific genetic mutations dictate T cell-augmenting immunotherapy outcomes
4 years ago
1
Image credit: National Cancer Institute
Is it original or innovative?
Is it feasible?
Is it targeting an unsolved problem?
Is it concisely described?
Provide a bounty for the best solution
Bounties attract serious brainpower to the challenge.
Please leave the feedback on this idea
Please leave the feedback on this idea
Please leave the feedback on this idea
Please leave the feedback on this idea